ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 72 filers reported holding ALIGOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,012,000 | -97.6% | 471,140 | -86.8% | 0.00% | -100.0% |
Q4 2021 | $42,281,000 | -28.8% | 3,561,971 | -7.0% | 0.01% | -30.0% |
Q3 2021 | $59,393,000 | -30.2% | 3,829,383 | -8.3% | 0.01% | -28.6% |
Q2 2021 | $85,118,000 | -6.2% | 4,175,581 | +4.4% | 0.01% | -12.5% |
Q1 2021 | $90,790,000 | -15.2% | 3,999,289 | +1.8% | 0.02% | -20.0% |
Q4 2020 | $107,110,000 | – | 3,927,598 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |